InsiderSignal.AI

InsiderSignal.ai

MIRM - Mirum Pharmaceuticals, Inc.

Insider Sale by Ramasastry Saira (Dir)

1 Month
After Trade
Before Trade

Loading data...

Trade Summary

2 days ago, Ramasastry Saira, serving as Dir at Mirum Pharmaceuticals, Inc. (MIRM), sold 2,000 shares at $90.76 per share, for a total transaction value of $181,520.00.

This sale represents a 100.00% decrease in Ramasastry Saira's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Monday, March 16, 2026 and publicly disclosed via SEC Form 4 filing on Tuesday, March 17, 2026, 1 day after the trade was made.

Mirum Pharmaceuticals, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.

Ramasastry Saira

Ramasastry Saira

Dir

Saira Ramasastry is a seasoned life sciences executive and Managing Partner of Life Sciences Advisory, LLC, an independent impact firm she founded to accelerate cures for patients by providing strategic advice and business development solutions.[[1]](https://www.vir.bio/team/saira-ramasastry/)[[2]](https://kriyatherapeutics.com/saira-ramasastry/) She serves as a Director on the board of Mirum Pharmaceuticals, Inc. (MIRM), a position she has held since September 2019, and is also a member of its Audit Committee.[[1]](https://www.vir.bio/team/saira-ramasastry/)[[3]](https://in.marketscreener.com/quote/stock/MIRUM-PHARMACEUTICALS-INC-61871306/news/Mirum-Pharmaceuticals-Inc-Appoints-Saira-Ramasastry-to-the-Board-of-Directors-and-as-A-Member-of-t-40660199/)[[5]](https://ir.mirumpharma.com/governance/board-of-directors/person-details/default.aspx?ItemId=092442f2-6cd2-4e55-bca8-8dad13dfbee4)[[6]](https://ir.mirumpharma.com/news/news-details/2022/Mirum-Pharmaceuticals-Appoints-Saira-Ramasastry-to-Board-of-Directors/default.aspx) Prior to founding her firm, Ramasastry spent 10 years as an investment banker at Merrill Lynch & Co., Inc., where she helped establish the biotechnology practice and originated mergers, acquisitions, strategic, and capital markets transactions; she previously worked as a financial analyst in the M&A group at Wasserstein Perella & Co..[[1]](https://www.vir.bio/team/saira-ramasastry/)[[2]](https://kriyatherapeutics.com/saira-ramasastry/) She holds a B.A. in economics (with Honors and Distinction), an M.S. in management science and engineering from Stanford University, and an M.Phil. in management studies from the University of Cambridge, where she serves as a guest lecturer.[[1]](https://www.vir.bio/team/saira-ramasastry/)[[2]](https://kriyatherapeutics.com/saira-ramasastry/) Ramasastry also serves on the boards of DayOne Biopharmaceuticals, Inc., Glenmark Pharmaceuticals Ltd., and others, and is a Health Innovator Fellow of the Aspen Institute.[[1]](https://www.vir.bio/team/saira-ramasastry/)[[2]](https://kriyatherapeutics.com/saira-ramasastry/)[[6]](https://ir.mirumpharma.com/news/news-details/2022/Mirum-Pharmaceuticals-Appoints-Saira-Ramasastry-to-Board-of-Directors/default.aspx)

View full insider profile →

Trade Price

$90.76

Quantity

2,000

Total Value

$181,520.00

Shares Owned

0

Trade Date

Monday, March 16, 2026

2 days ago

SEC Filing Date

Tuesday, March 17, 2026

Filed 1 day after trade

HEALTHCAREBIOTECHNOLOGY

About Mirum Pharmaceuticals, Inc.

Company Overview

No company information available
View news mentioning MIRM

💬 Want Deeper Insight?

Use our AI assistant to ask questions about this trade, the insider, or the company.

Chat with AI

Share this trade

https://insidersignal.ai/trade/4871458

🚀 Track Insider Trades in Real-Time

Create a free account to access our full database of insider trades, AI-powered analysis, price alerts, and discover what corporate executives are buying and selling.

Create Free AccountLearn More

✓ Free forever plan available  •  ✓ No credit card required  •  ✓ Cancel anytime